4//SEC Filing
PAKIANATHAN DEEPIKA 4
Accession 0001415889-25-014022
CIK 0001583107other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 7:20 PM ET
Size
7.2 KB
Accession
0001415889-25-014022
Insider Transaction Report
Form 4
PAKIANATHAN DEEPIKA
Director
Transactions
- Award
Ordinary Shares
2025-05-19+10,649→ 58,065 total - Award
Share Option (Right to Buy)
2025-05-19+24,258→ 24,258 totalExercise: $9.39Exp: 2035-05-18→ Ordinary Shares (24,258 underlying)
Footnotes (1)
- [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001270734
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 7:20 PM ET
- Size
- 7.2 KB